Page 9 - மைய மருந்து தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Welcome To IANS Live - NATION - After Covishield , expert panel recommends Bharat Biotech s Covaxin for emergency use

Photo Credit: IANS IANSLive New Delhi, Jan 2 (IANS) The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech s Covaxin for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI). To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 02-January-2021

New delhiNews serviceIndia privateBharat biotechSubject expert committeeCentral drug standard control organizationDrug controllerAll rightsபுதியது டெல்ஹிசெய்தி சேவைஇந்தியா ப்ரைவேட்பாரத் பயோடெக்பொருள் நிபுணர் குழுமைய மருந்து தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்மருந்து கட்டுப்படுத்திஅனைத்தும் உரிமைகள்

DCGI panel calls Bharat Biotech officials to meet over Covaxin vaccine today

DCGI panel calls Bharat Biotech officials to meet over Covaxin vaccine today India Published: Saturday, January 2, 2021, 16:22 [IST] New Delhi, Jan 02: A committee of experts assessing the coronavirus vaccines has called Hyderabad-based Bharat Biotech for a meeting on Saturday, a day after the firm was asked to present more data on its Covaxin to get the go-ahead, a top source said. Representational Image Earlier, the panel recommended emergency licensure for the Serum Institute of India s Covishield vaccine, making it the first in India to secure approval for emergency use. However, nod of the Durg Controller General of India is, however, awaited on the recommendation.

New delhiBriti roy barmanSerum institute of india covishieldSerum instituteIndian council of medical researchBharat biotechBriti royHyderabad based bharat biotechDurg controller generalSubject expert committeeCentral drug standard control organisationPune based serum instituteIndian councilMedical researchBreaking newsInstant updates

No emergency approval for Covaxin, expert panel seeks more data from Bharat Biotech

No emergency approval for Covaxin, expert panel seeks more data from Bharat Biotech
mid-day.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mid-day.com Daily Mail and Mail on Sunday newspapers.

United statesUnion territoriesSerum institute of covishieldSerum instituteIndian council of medical researchSubject expert committeeCentral drug standard control organisationBharat biotechPune based serum instituteIndian councilMedical researchSerum insstituteஒன்றுபட்டது மாநிலங்களில்தொழிற்சங்கம் பிரதேசங்கள்சீரம் நிறுவனம்இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி

No approval for Indian COVID vaccine, expert panel seeks more data from Bharat Biotech

No approval for Indian COVID vaccine, expert panel seeks more data from Bharat Biotech
indianewengland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianewengland.com Daily Mail and Mail on Sunday newspapers.

United statesNew delhiUnion territoriesSerum institute of covishieldSerum instituteIndian council of medical researchSubject expert committeeCentral drug standard control organisationBharat biotechPune based serum instituteIndian councilMedical researchSerum insstituteஒன்றுபட்டது மாநிலங்களில்புதியது டெல்ஹிதொழிற்சங்கம் பிரதேசங்கள்

Covaxin vaccine: DCGI panel to meet Bharat Biotech officials shortly | India News

NEW DELHI: Subject Expert Committee (SEC) of the national drug regulator is likely to hold a meeting with Bharat Biotech on Saturday to consider its Covid-19 vaccine applicant, Covaxin. The committee constituted by Central Drug Standard Control Organisation on Friday had maintained that the data provided by Bharat Biotech for its coronavirus vaccine is not sufficient for grant of emergency use approval and had asked for more information. The committee had convened a meeting to take a call on the emergency use authorisation sought by the Serum Institute, Bharat Biotech and America s Pfizer for their coronavirus vaccines candidates. The expert committee, which is tasked with vetting covid-19 vaccine proposals, recommended emergency licensure for the Serum Institute of India-manufactured Covishield . It becomes the first vaccine to secure a recommendation for emergency use in India.

United statesSerum institute of covishieldSerum instituteIndian council of medical researchExpert committeeCentral drug standard control organisation onSubject expert committeeBharat biotechCentral drug standard control organisationPune based serum instituteIndian councilMedical researchIndia newsIndia news todayToday newsGoogle news